Navigation Links
Elanco Announces Commitment to Fight World Hunger
Date:6/2/2011

GREENFIELD, Ind., June 2, 2011 /PRNewswire/ -- As global food insecurity reaches all-time highs, Elanco seeks to be an example of how one company can impact this growing crisis. Today, the company announced its commitment to end hunger for 100,000 families globally through a partnership with Heifer International.

Elanco, a division of Eli Lilly and Company, a leading global pharmaceutical corporation, is also dedicated to helping create a hunger-free community for children around its central Indiana headquarters.  Elanco's hunger initiative, with significant funding from the Lilly Foundation, is an extension of Lilly's overall corporate responsibility efforts, which also include: improving the health of undeserved people, improving U.S. public education, supporting people and communities through United Way and similar efforts, and environmental stewardship.

"We believe every person is born with the right to a hopeful future, and the right to be fed," said Jeff Simmons, Elanco president and Senior Vice President of Eli Lilly and Company. "But today, 1 in 6 people globally are hungry. More than 25,000 people die each day from hunger and malnutrition. That's like 60 fully loaded jumbo jets crashing each and every day." As the population grows toward 9 billion at mid-century, the problem of hunger could grow staggeringly.

Through Elanco's partnership with Heifer, they will identify small communities in emerging countries that could substantially benefit from the gift of an animal, as well as training in animal husbandry, health care and other practices. Heifer's sustainable model is built on recipients "Passing of the Gift" of their animal's first female offspring to other community members.

Already Elanco and Heifer have begun work in two communities. Elanco's first project with Heifer began in 2009 in the Lampung province of Indonesia. The five-year project will provide 2,100 families with cattle, ducks, plants and trees. Elanco
'/>"/>

SOURCE Elanco
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Elanco Launches Broad-Spectrum Canine Parasiticide
2. Goodwin Biotechnology Announces a Collaboration With Alethia Biotherapeutics
3. IDEV Technologies Announces Completion of SUPERB Clinical Trial Enrollment
4. Syndax Pharmaceuticals Announces Issuance of US Patent for Entinostat
5. China Kanghui Holdings Announces Participation in Upcoming Investor Conferences
6. Jazz Pharmaceuticals Announces Presentation at the Jefferies 2011 Global Healthcare Conference in New York on June 8
7. Misonix Announces Exclusive U.S. Distribution Agreement For Advanced Wound Care Product
8. Anadys Announces Issuance of U.S. Patent Covering Setrobuvir (ANA598)
9. EndoSphere Inc. Announces Pivotal Financing Led by Broadline Capital
10. Generex Announces Intention to Dividend a Portion of Anticipated Amarantus BioSciences Shares to Its Shareholders upon a Reverse Stock Split
11. Mettler-Toledo International Inc. Announces Webcast of Presentation at Jefferies Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Relmada Therapeutics, Inc. (OTCQB: RLMD; RLMDD), a ... chronic pain, announced today that the company,s management will ... Annual Healthcare Conference and BioCentury NewsMakers Conference.  Details of ... Annual Healthcare Conference Date:  Wednesday, September 9 ... No presentation, investor meetings only BioCentury NewsMakers ...
(Date:9/2/2015)... 2015 Tumultuous market conditions – including changes ... M&A activity – have led more than half of ... sales reps. This marks the first time that the ... halfway point, according to the spring 2015 AccessMonitor™ ... ZS . AccessMonitor™ aggregates sales-call ...
(Date:9/2/2015)... VANCOUVER, British Columbia and ...   DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on the development and commercialization of new cancer ... abstract entitled, "A Comparison of the Mechanisms ... in Ovarian Tumor Models Harboring Wild-type and Mutant ...
Breaking Medicine Technology:Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2Crossing the threshold: More than half of physicians restrict access to sales reps 2Crossing the threshold: More than half of physicians restrict access to sales reps 3Crossing the threshold: More than half of physicians restrict access to sales reps 4Crossing the threshold: More than half of physicians restrict access to sales reps 5DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 2DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 3DelMar Pharmaceuticals Announces Expansion of VAL-083 Development Program to Include Ovarian Cancer 4
... 15, 2012 Grifols (MCE:GRF, MCE:GRF.P and NASDAQ: ... manufacturer and a pioneer in the research and development ... and social development, has acquired 51% of the equity ... its projects and the future of the company. ...
... 2012   CSL Behring announced today that the ... REPLACE Phase III clinical trial evaluating the efficacy and ... bleeding during aortic aneurysm surgery. The ... Concentrate (Human)(FCH) can reduce intraoperative bleeding and, therefore, the ...
Cached Medicine Technology:Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 3Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 4Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 5Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 6Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 7Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 8CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery 2CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery 3CSL Behring Announces First Patient Treated in Phase III Study of Fibrinogen Concentrate (Human)(FCH) to Control Bleeding During Aortic Aneurysm Surgery 4
(Date:9/2/2015)... Las Vegas, NV (PRWEB) , ... September 02, ... ... Las Vegas and Fort Lauderdale, CENTURION SERVICE GROUP is internationally known as an ... largest medical auction house in the world, selling more than 100,000 pieces of ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... helping to bring awareness to International Overdose Awareness Day. The goal is to ... recognize the warning signs so that they may get help. , ...
(Date:9/2/2015)... ... 2015 , ... Please join the world renowned Brain Aneurysm ... established by the Foundation in 2007 with the help of Massachusetts State Representative ... remains our top priority,” commented Christine Buckley, Executive Director of the Brain Aneurysm ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... of Breast Cancer Awareness Month (BCAM), Bright Pink, a national non-profit focused on ... will launch Act On Facts, a campaign to educate women to be breast ...
(Date:9/1/2015)... ... September 01, 2015 , ... An August 25 ... of plastic surgeries conducted each year on teenagers, quoting a New York City-area ... Beverly Hills-based plastic surgeon Payam Jarrah-Nejad, M.D., F.I.C.S., F.A.C.S., known more familiarly to ...
Breaking Medicine News(10 mins):Health News:Over 1800 Lots of Surplus Used Medical Equipment 2Health News:Over 1800 Lots of Surplus Used Medical Equipment 3Health News:August 31 is International Overdose Awareness Day – Lakeview Health to Help Bring Awareness 2Health News:September Celebrated as Brain Aneurysm Awareness Month 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 2Health News:Bright Pink Launches Act On Facts™, A Campaign To Empower Young Women To Take Action Related To Their Breast And Ovarian Health 3Health News:Teen Plastic Surgery Article Understates the Most Important Realities of Procedures on Young People, Notes Dr. J 2
... January 12, 2010 (BRONX, NY) Older women ... lesions that cause dementia later in life, according to ... The findings were published in the December 2009 online ... The research was conducted as part of the ...
... WINSTON-SALEM, N.C. A fast-acting compound that appears to ... found in patients with progressive Alzheimer,s disease has been ... Medicine and the Vanderbilt University Medical Center Program in ... result in humans. The compound benzylquinolone carboxylic ...
... ... Molecular Medicine. Molecular Medicine publishes research concerned with the pathogenesis of disease at the ... prevention. , ... January 12, 2010 -- By the time a person experiences symptoms of an aggressive ...
... , DETROIT , Jan. 12 ... Board of Directors has set the date for the Company,s Annual Meeting ... vote at the meeting.   , The Annual Shareholders, Meeting will be ... EST at the MGM Grand Hotel, 1777 Third Street in ...
... hospice and preferred place of death are often needed, experts ... patients have much to consider, from whether they want to ... want doctors to continue aggressive treatment or focus on making ... those difficult, emotional conversations aren,t happening nearly as often, or ...
... WASHINGTON , Jan. 12 The American Lung ... report, which grades the strength of federal and state ... at the heart of America,s chronic disease crisis. , The ... still has significant room for progress. Most state governments , ...
Cached Medicine News:Health News:Hypertension linked to dementia in older women 2Health News:Hypertension linked to dementia in older women 3Health News:New compound improves cognitive decline, symptoms of Alzheimer's disease in rodents 2Health News:New compound improves cognitive decline, symptoms of Alzheimer's disease in rodents 3Health News:News from the Latest Issue of Molecular Medicine 2Health News:United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders 2Health News:United American Healthcare Corporation Announces Meeting Date and Record Date for Annual Meeting of Shareholders 3Health News:Doctors Put Off End-of-Life Talks With Terminally Ill 2Health News:Doctors Put Off End-of-Life Talks With Terminally Ill 3Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 2Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 3Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 4Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 5Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 6Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 7Health News:American Lung Association Report Card: Federal Government Makes Major Strides; Most States Flunk for Neglecting to Prevent Tobacco-Caused Disease 8
3.2% Tryptone, 2.0% Yeast Extract, 0.5% Sodium Chloride, pH 7.5....
... Evolve™ modular radial head system employs the ... research to create the next generation of ... two part, modular design, the implant system ... match the patients anatomy. In addition, the ...
For connection to the bipolar output of electrosurgical generators....
Recommended for use with spark gap coagulators for added safety. Also available in stainless steel (10-3002)....
Medicine Products: